Research Article
Soluble Sema4D Level Is Positively Correlated with Sema4D Expression in PBMCs and Peripheral Blast Number in Acute Leukemia
Figure 4
Sema4D expression is reduced in B-ALL patients during the chemotherapy process. (a) Comparison of Sema4D expression in the BMMCs of newly diagnosed patients (D0) and patients who received chemotherapy for 15 (D15), 33 (D33), and 88 days (D88); solid dots: no remission; empty dots: remission. (b) Comparison of Sema4D expression in BMMCs among newly diagnosed patients, patients without remission, and remission patients. , , , and ; ns: not significant.
(a) |
(b) |